Provided by Tiger Trade Technology Pte. Ltd.

Acurx Pharmaceuticals, LLC*

1.45
-0.0700-4.61%
Post-market: 1.450.00000.00%17:56 EST
Volume:76.14K
Turnover:110.93K
Market Cap:3.69M
PE:-0.18
High:1.52
Open:1.51
Low:1.42
Close:1.52
52wk High:21.00
52wk Low:1.41
Shares:2.55M
Float Shares:2.42M
Volume Ratio:1.40
T/O Rate:3.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.1800
EPS(LYR):-17.4507
ROE:-291.07%
ROA:-95.64%
PB:1.02
PE(LYR):-0.08

Loading ...

Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 06, 2023

Correspondence

Form CORRESP - Correspondence
Jun 30, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 16, 2023

Major Issues Report

8-K - Current report
Mar 15, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]